Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07531810

Patient-Reported Outcomes and Complications After Structural Rhinoplasty Using Septal Extension Grafts

Structural rhinoplasty with septal extension graft (SEG) is commonly used to achieve stable nasal tip support and predictable long-term outcomes. However, surgical success is not limited to structural stability alone and should also be evaluated from the patient's perspective.

Patient-reported outcome measures (PROMs) have gained increasing importance in rhinoplasty, as they reflect patient satisfaction and perceived nasal function. Despite the widespread use of SEG, prospective studies evaluating PROMs together with postoperative clinical findings over time remain limited.

This prospective observational cohort study aims to evaluate longitudinal changes in patient-reported outcomes and postoperative findings in adult patients undergoing primary structural rhinoplasty with SEG-based nasal tip support. Validated PROM instruments will be applied preoperatively and during routine postoperative follow-up visits at approximately 1, 3, and 6 months.

In addition, postoperative complications and revision procedures will be recorded. The study aims to provide a more comprehensive understanding of patient-centered outcomes and their relationship with clinical findings in SEG-based rhinoplasty.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Sivas Cumhuriyet University

Sivas, 58070, Turkey (Türkiye)

Location status: Recruiting

Location contact

Handan Derebaşınlıoğlu, Associate Professor

CONTACT

[email protected]

+905322408767

Handan Derebaşınlıoğlu, Associate Professor

PRINCIPAL_INVESTIGATOR

Murat Çelik, Assistant Professor

CONTACT

05546902104

About this study

Structural rhinoplasty is performed to achieve stable and lasting aesthetic and functional outcomes by rebuilding and maintaining the nasal framework. Among nasal tip support techniques, the septal extension graft (SEG) is widely used due to its ability to provide reliable control of nasal tip projection and rotation while maintaining structural stability.

Surgical success in rhinoplasty is not limited to anatomical outcomes alone. Patient perception of nasal function and appearance plays a key role in overall satisfaction. Therefore, patient-reported outcome measures (PROMs) have become an important component in outcome assessment.

Despite the widespread use of SEG, prospective data evaluating longitudinal changes in PROMs together with postoperative clinical findings remain limited. Clinical factors such as tip stiffness, palpable grafts, columellar deviation, and the need for revision surgery may influence patient-reported outcomes, but their relationship with PROM score changes over time has not been clearly defined.

This study is designed as a single-center, prospective observational cohort including consecutive adult patients undergoing primary structural rhinoplasty with SEG-based tip support. All procedures will be performed by the same surgical team using a standardized structural approach, with additional techniques applied as required based on individual anatomical characteristics.

Patient-reported outcomes will be assessed using validated instruments, including the Standardized Cosmesis and Health Nasal Outcomes Survey (SCHNOS), the Rhinoplasty Outcome Evaluation (ROE), and the Nasal Obstruction Symptom Evaluation (NOSE) scale. Assessments will be performed preoperatively and at postoperative follow-up visits.

Follow-up evaluations are planned at approximately 1, 3, and 6 months. Early postoperative assessments may be influenced by edema; therefore, later time points will be considered more representative of stable outcomes.

Data will be collected prospectively using standardized case report forms with predefined variables. PROM data will be obtained through patient-completed questionnaires at each visit. Clinical findings, including postoperative status and complications, will be recorded during routine follow-up examinations. Data entry will be performed contemporaneously at each visit.

Postoperative complications will be recorded and categorized according to timing. Revision procedures occurring during the follow-up period will also be documented. The study is structured to allow evaluation of longitudinal changes in PROM scores and to explore potential associations between patient-reported outcomes and clinical findings.

Consecutive patient inclusion will be used to reduce selection bias. Data quality will be supported by predefined variable definitions, consistency checks, and periodic data review. Missing data will be documented and handled using appropriate statistical methods for repeated measures analyses.

This study aims to characterize longitudinal changes in PROM scores and their relationship with postoperative clinical findings in patients undergoing SEG-based structural rhinoplasty.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age 18 years or older
  • Undergoing primary structural rhinoplasty with septal extension graft
  • Able to understand and complete patient-reported outcome questionnaires (PROMs)
  • Willing to participate and provide written informed consent

Exclusion criteria

  • History of previous nasal surgery (revision rhinoplasty)
  • Undergoing concomitant major craniofacial procedures
  • Missing preoperative PROM data
  • Unable to complete postoperative follow-up assessments

Treatment and study plan

Primary outcomes

  1. Change from Baseline in Total Standardized Cosmesis and Health Nasal Outcomes Survey (SCHNOS) Score at Postoperative Month 6

    Time frame: Baseline to postoperative month 6

    Change in the total score of the Standardized Cosmesis and Health Nasal Outcomes Survey (SCHNOS) from preoperative baseline to postoperative month 6. The SCHNOS score ranges from 0 to 100, with higher scores indicating worse nasal symptoms and poorer aesthetic outcomes. Postoperative month 6 represents a time point at which most postoperative edema has subsided and nasal structures are relatively stable.

Secondary outcomes

  1. Change from Baseline in Rhinoplasty Outcome Evaluation (ROE) Score at Postoperative Month 6

    Time frame: Baseline to postoperative month 6

    Change in the score of the Rhinoplasty Outcome Evaluation (ROE) from preoperative baseline to postoperative month 6. The ROE score ranges from 0 to 100, with higher scores indicating better patient satisfaction and improved outcomes

  2. Change from Baseline in Nasal Obstruction Symptom Evaluation (NOSE) Score at Postoperative Month 6

    Time frame: Baseline to postoperative month 6

    Change in the score of the Nasal Obstruction Symptom Evaluation (NOSE) scale from preoperative baseline to postoperative month 6. The NOSE score ranges from 0 to 100, with higher scores indicating more severe nasal obstruction symptoms.

  3. Revision Surgery Rate Within 6 Months

    Time frame: Up to postoperative month 6

    Proportion of patients requiring revision surgery within 6 months following the primary rhinoplasty procedure.

Other outcomes

  1. Change from Baseline in Total Standardized Cosmesis and Health Nasal Outcomes Survey (SCHNOS) Score at Postoperative Month 1

    Time frame: Baseline to postoperative month 1

    Change in the total score of the Standardized Cosmesis and Health Nasal Outcomes Survey (SCHNOS) from preoperative baseline to postoperative month 1. The SCHNOS total score ranges from 0 to 100, with higher scores indicating worse nasal symptoms and poorer aesthetic outcomes.

  2. Change from Baseline in Total Standardized Cosmesis and Health Nasal Outcomes Survey (SCHNOS) Score at Postoperative Month 3

    Time frame: Baseline to postoperative month 3

    Change in the total score of the Standardized Cosmesis and Health Nasal Outcomes Survey (SCHNOS) from preoperative baseline to postoperative month 3. The SCHNOS total score ranges from 0 to 100, with higher scores indicating worse nasal symptoms and poorer aesthetic outcomes.

  3. Change from Baseline in Rhinoplasty Outcome Evaluation (ROE) Score at Postoperative Month 1

    Time frame: Baseline to postoperative month 1

    Change in the score of the Rhinoplasty Outcome Evaluation (ROE) from preoperative baseline to postoperative month 1. The ROE score ranges from 0 to 100, with higher scores indicating better patient satisfaction and improved outcomes.

  4. Change from Baseline in Rhinoplasty Outcome Evaluation (ROE) Score at Postoperative Month 3

    Time frame: Baseline to postoperative month 3

    Change in the score of the Rhinoplasty Outcome Evaluation (ROE) from preoperative baseline to postoperative month 3. The ROE score ranges from 0 to 100, with higher scores indicating better patient satisfaction and improved outcomes.

Study contacts

Contact information is provided by the study sponsor or research team.

Handan Derebaşınlıoğlu, Associate Professor

CONTACT

[email protected]

+905322408767

Murat Çelik, Assistant Professor

CONTACT

[email protected]

+905546902104

Sponsors and collaborators

Lead sponsor

Cumhuriyet University Hospital

Other

Registry information

Official study title

Patient-Reported Outcomes and Complications Following Structural Rhinoplasty Using Septal Extension Grafts: A Prospective Cohort Study

Acronym: SEG-PROM

Important dates

Study start
2026
Primary completion
2027
Study completion
2027
First posted
Apr 15, 2026
Registry last updated
Jun 22, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.